{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T15:32:27Z","timestamp":1774452747075,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T00:00:00Z","timestamp":1575590400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009776","name":"Region\u00a0G\u00e4vleborg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009776","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.ijcha.2019.100452","type":"journal-article","created":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T19:46:25Z","timestamp":1576784785000},"page":"100452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Positron emission tomography (15O-water, 11C-acetate, 11C-HED) risk markers and nonsustained ventricular tachycardia in hypertrophic cardiomyopathy"],"prefix":"10.1016","volume":"26","author":[{"given":"Peter","family":"Magnusson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonny","family":"Nordstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hendrik J.","family":"Harms","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Lubberink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredrik","family":"Gadler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"S\u00f6rensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stellan","family":"M\u00f6rner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcha.2019.100452_b0005","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1161\/CIR.0b013e318223e230","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"124","author":"Gersh","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ijcha.2019.100452_b0010","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcha.2019.100452_b0015","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","article-title":"Hypertrophic Cardiomyopathy Outcomes I. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)","volume":"35","author":"O'Mahony","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcha.2019.100452_b0020","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1161\/CIRCULATIONAHA.117.030437","article-title":"International external validation study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM)","volume":"137","author":"O'Mahony","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.ijcha.2019.100452_b0025","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/CIRCHEARTFAILURE.112.969626","article-title":"Outcome and complications after implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: systematic review and meta-analysis","volume":"5","author":"Schinkel","year":"2012","journal-title":"Circ Heart Fail."},{"key":"10.1016\/j.ijcha.2019.100452_b0030","article-title":"Can positron emission tomography help stratify the risk of sudden cardiac death in patients with hypertrophic cardiomyopathy?","volume":"14","author":"Kay","year":"2018","journal-title":"J. Nucl. Cardiol."},{"key":"10.1016\/j.ijcha.2019.100452_b0035","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/europace\/euu233","article-title":"Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry","volume":"17","author":"Gadler","year":"2015","journal-title":"EP Europace"},{"key":"10.1016\/j.ijcha.2019.100452_b0040","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1007\/s00259-011-1730-3","article-title":"Automatic generation of absolute myocardial blood flow images using [15O] H2O and a clinical PET\/CT scanner","volume":"38","author":"Harms","year":"2011","journal-title":"Eur. J. Nucl. Med. Mol. Imaging."},{"key":"10.1016\/j.ijcha.2019.100452_b0045","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40658-015-0133-0","article-title":"Automatic extraction of forward stroke volume using dynamic PET\/CT: a dual-tracer and dual-scanner validation in patients with heart valve disease","volume":"2","author":"Harms","year":"2015","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.ijcha.2019.100452_b0050","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/hc0402.102975","volume":"105","author":"Cerqueira","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ijcha.2019.100452_b0055","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11307-005-0007-2","article-title":"Evaluation of basis function and linear least squares methods for generating parametric blood flow images using 15O-water and Positron Emission Tomography","volume":"7","author":"Boellaard","year":"2005","journal-title":"Mol Imaging Biol."},{"key":"10.1016\/j.ijcha.2019.100452_b0060","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.amjcard.2018.01.022","article-title":"Stress myocardial blood flow heterogenity is a positron emission tomography biomarker of ventricular arrhytmias in patients with hypertrophic cardiomyopathy","volume":"121","author":"Lu","year":"2018","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcha.2019.100452_b0065","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s12350-018-1338-0","article-title":"Automatic calculation of myocardial external efficiency using a single 11C-adetate PET scan","volume":"25","author":"Harms","year":"2018","journal-title":"J. Nucl. Card."},{"key":"10.1016\/j.ijcha.2019.100452_b0070","first-page":"272","article-title":"Simultaneous measurement of myocardial oxygen consumption and blood flow using [1-carbon-11] acetate","volume":"39","author":"Sun","year":"1998","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ijcha.2019.100452_b0075","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13550-014-0052-4","article-title":"Quantification of [11-C]-meta-hydroxyephederine uptake in human myocardium","volume":"4","author":"Harms","year":"2014","journal-title":"EJNMMI Res."},{"key":"10.1016\/j.ijcha.2019.100452_b0080","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1161\/CIRCRESAHA.115.305364","article-title":"The Human Microcirculation: Regulation of Flow and Beyond","volume":"118","author":"Gutterman","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcha.2019.100452_b0085","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1053\/hupa.2000.16659","article-title":"Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia","volume":"31","author":"Basso","year":"2000","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.ijcha.2019.100452_b0090","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.jacc.2009.04.072","article-title":"The case for myocardial ischemia in hypertrophic cardiomyopathy","volume":"54","author":"Maron","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcha.2019.100452_b0095","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.CIR.97.3.230","article-title":"Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodeling of the coronary microcirculation","volume":"97","author":"Krams","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ijcha.2019.100452_b0100","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0735-1097(98)00036-9","article-title":"Alterations of the architecture of subendocardial arterioles in patients with hypertrophic cardiomyopathy and impaired coronary vasodilator reserve: a possible cause for myocardial ischemia","volume":"31","author":"Schwartzkopff","year":"1998","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcha.2019.100452_b0105","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0735-1097(10)80145-7","article-title":"Pathologic fibrosis and matrix connective tissue in the subaortic myocardium of patients with hypertrophic cardiomyopathy","volume":"17","author":"Factor","year":"1991","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcha.2019.100452_b0110","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/0735-1097(89)90105-8","article-title":"Noninvasive quantitation of myocardial blood flow in human subjects with oxygen-15-labeled water and positron emission tomography","volume":"14","author":"Bergmann","year":"1989","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcha.2019.100452_b0115","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.jacc.2014.05.069","article-title":"Quantitative assessment of myocardial perfusion in the detection of significant coronary artery disease: cutoff values and diagnostic accuracy of quantitative [(15)O]H2O PET imaging","volume":"64","author":"Danad","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcha.2019.100452_b0120","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1001\/jamacardio.2017.2471","article-title":"Comparison of coronary CT angiography, SPECT, PET, and hybrid imaging for diagnosis of ischemic heart disease determined by fractional flow reserve","volume":"2","author":"Danad","year":"2017","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ijcha.2019.100452_b0125","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1152\/ajpheart.00233.2007","article-title":"Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy","volume":"294","author":"Knaapen","year":"2008","journal-title":"Am. J. Physiol. Heart Circ Physiol."},{"key":"10.1016\/j.ijcha.2019.100452_b0130","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1161\/01.CIR.75.6.1130","article-title":"Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts, and hearts with hypertrophic cardiomyopathy","volume":"75","author":"Tanaka","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.ijcha.2019.100452_b0135","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0735-1097(86)80181-4","article-title":"Intramural (\u201csmall vessel\u201d) coronary artery disease in hypertrophic cardiomyopathy","volume":"8","author":"Maron","year":"1986","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcha.2019.100452_b0140","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1161\/01.CIR.92.4.978","article-title":"Hemodynamic mechanisms responsible for reduced subendocardial coronary reserve in dogs with severe left ventricular hypertrophy","volume":"92","author":"Hittinger","year":"1995","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ijcha.2019.100452_b0145","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s003950050126","article-title":"Transmural myocardial blood flow distribution in hypertrophic cardiomyopathy and effect of treatment","volume":"94","author":"Choudhury","year":"1999","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.ijcha.2019.100452_b0150","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0002-9149(94)90404-9","article-title":"Effect of verapamil on absolute myocardial blood flow in hypertrophic cardiomyopathy","volume":"74","author":"Gistri","year":"1994","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcha.2019.100452_b0155","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s00259-016-3603-2","article-title":"Myocardial blood flow and left ventricular functional reserve in hypertrophic cardiomyopathy: a 13NH3 gated PET study","volume":"44","author":"Sciagr\u00e0","year":"2017","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ijcha.2019.100452_b0160","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.amjcard.2016.08.085","article-title":"Effect of Diffuse Subendocardial Hypoperfusion on Left Ventricular Cavity Size by 13N-Ammonia Perfusion PET in Patients With Hypertrophic Cardiomyopathy","volume":"118","author":"Yal\u00e7in","year":"2016","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcha.2019.100452_b0165","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMoa025050","article-title":"Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy","volume":"349","author":"Cecchi","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcha.2019.100452_b0170","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1007\/s00259-016-3465-7","article-title":"Role of quantitative myocardial positron emission tomography for risk stratification in patients with hypertrophic cardiomyopathy: a 2016 reappraisal","volume":"43","author":"Castagnoli","year":"2016","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ijcha.2019.100452_b0175","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.amjcard.2018.01.022","article-title":"Stress Myocardial Blood Flow Heterogeneity Is a Positron Emission Tomography Biomarker of Ventricular Arrhythmias in Patients With Hypertrophic Cardiomyopathy","volume":"121","author":"Lu","year":"2018","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcha.2019.100452_b0180","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/ehjci\/jes242","article-title":"Coronary microvascular function, myocardial metabolism, and energetics in hypertrophic cardiomyopathy: insights from positron emission tomography","volume":"14","author":"Timmer","year":"2013","journal-title":"Eur. Heart J. Cardiovasc. Imaging."},{"key":"10.1016\/j.ijcha.2019.100452_b0185","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1161\/01.CIR.80.4.863","article-title":"Regional myocardial oxygen consumption determined noninvasively in humans with [1-11C]acetate and dynamic positron tomography","volume":"80","author":"Armbrecht","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.ijcha.2019.100452_b0190","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.nuclcard.2006.12.329","article-title":"Myocardial perfusion, oxidative metabolism, and free fatty acid uptake in patients with hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene: a positron emission tomography study","volume":"14","author":"Tuunanen","year":"2007","journal-title":"J. Nucl. Cardiol."},{"key":"10.1016\/j.ijcha.2019.100452_b0195","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0002-8703(97)70143-1","article-title":"Mechanical efficiency in hypertrophic cardiomyopathy assessed by positron emission tomography with carbon 11 acetate","volume":"133","author":"Ishiwata","year":"1997","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcha.2019.100452_b0200","first-page":"390","article-title":"Impairment of BMIPP uptake precedes abnormalities in oxygen and glucose metabolism in hypertrophic cardiomyopathy","volume":"39","author":"Tadamura","year":"1998","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ijcha.2019.100452_b0205","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009974","article-title":"Myocardial oxygen consumption and efficiency in patients with cardiac amyloidosis","volume":"7","author":"Clemmensen","year":"2018","journal-title":"J Am Heart Assoc."},{"issue":"6","key":"10.1016\/j.ijcha.2019.100452_b0210","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s12350-018-1338-0","article-title":"Automatic calculation of myocardial external efficiency using a single 11C-acetate PET scan","volume":"25","author":"Harms","year":"2018","journal-title":"J. Nucl. Cardiol."},{"key":"10.1016\/j.ijcha.2019.100452_b0215","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00259-009-1350-3","article-title":"Determinants of myocardial energetics and efficiency in symptomatic hypertrophic cardiomyopathy","volume":"37","author":"Timmer","year":"2010","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ijcha.2019.100452_b0220","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1093\/eurjhf\/hfr135","article-title":"Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction","volume":"13","author":"Timmer","year":"2011","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcha.2019.100452_b0225","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1152\/ajpheart.00077.2011","article-title":"Effects of alcohol septal ablation on coronary microvascular function and myocardial energetics in hypertrophic obstructive cardiomyopathy","volume":"301","author":"Timmer","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ijcha.2019.100452_b0230","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jacc.2013.07.096","article-title":"Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy","volume":"63","author":"Fallavollita","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcha.2019.100452_b0235","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13550-014-0052-4","article-title":"Quantification of [(11)C]-meta-hydroxyephedrine uptake in human myocardium","volume":"4","author":"Harms","year":"2014","journal-title":"EJNMMI Res."},{"key":"10.1016\/j.ijcha.2019.100452_b0240","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.jacc.2010.01.014","article-title":"ADMIRE-HF Investigators. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study","volume":"55","author":"Jacobson","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcha.2019.100452_b0245","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/j.jacc.2009.12.066","article-title":"Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients","volume":"55","author":"Boogers","year":"2010","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906719302829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906719302829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T05:08:52Z","timestamp":1762492132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906719302829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":49,"alternative-id":["S2352906719302829"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2019.100452","relation":{},"ISSN":["2352-9067"],"issn-type":[{"value":"2352-9067","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Positron emission tomography (15O-water, 11C-acetate, 11C-HED) risk markers and nonsustained ventricular tachycardia in hypertrophic cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2019.100452","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100452"}}